Case: Pharmaceutical startup – ArinaPR

Arina PR

Case: Pharmaceutical startup

Problem To Be Solved
The client is a preclinical-stage pharmaceutical company developing new treatments for neuropsychiatric disorders, epilepsy and pain. It was founded in 2017 in Toronto.

Project description:
To improve image of the company in the eyes of investors. Because the cost of preclinical and clinical trials are very capital intensive, the company will have to raise tens and hundreds of million of dollars.

Project start date: February 2020


Solutions Used
– Media outreach and building media relationships; 
– Organizing interviews; 
– Expert comments; 
– Helping with organization of a virtual conference;  


Results
1. Successful media placements in: Business Insider, Forbes, Vice, Observer.com, Toronto Star, and more.
2. With help of arinaPR.com, the company got in front of investors and was able to close private financing round; went public on the Canadian Securities Exchange (CSE); had closed marketed public offering; and was uplisted to tier-1 US stock exchange.


  • Forbes
  • The Star
  • VICE
  • Observer.com

© 2026 ArinaPR LLC